QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Akero Therapeutics (AKRO) Short Interest Ratio & Short Volume

$25.34
+1.13 (+4.67%)
(As of 02/23/2024 ET)

Akero Therapeutics Short Interest Data

Current Short Volume
7,760,000 shares
Previous Short Volume
7,600,000 shares
Change Vs. Previous Month
+2.11%
Dollar Volume Sold Short
$167.69 million
Short Interest Ratio / Days to Cover
7.2
Last Record Date
January 31, 2024
Outstanding Shares
55,700,000 shares
Percentage of Shares Shorted
13.93%
Today's Trading Volume
1,492,685 shares
Average Trading Volume
959,185 shares
Today's Volume Vs. Average
156%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Akero Therapeutics ?

Sign up to receive the latest short interest report for Akero Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AKRO Short Interest Over Time

AKRO Days to Cover Over Time

AKRO Percentage of Float Shorted Over Time


Akero Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20247,760,000 shares $167.69 million +2.1%N/A7.2 $21.61
1/15/20247,600,000 shares $170.54 million +3.1%N/A6.3 $22.44
12/31/20237,370,000 shares $172.09 million +12.4%N/A3.8 $23.35
12/15/20236,560,000 shares $150.29 million +3.0%N/A3.4 $22.91
11/30/20236,370,000 shares $106.63 million +3.6%N/A3.4 $16.74
11/15/20236,150,000 shares $90.10 million +4.4%N/A3.3 $14.65
10/31/20235,890,000 shares $70.21 million -3.6%N/A3.3 $11.92
10/15/20236,110,000 shares $89.39 million +5.7%N/A3.8 $14.63
9/30/20235,780,000 shares $292.35 million -3.5%N/A4.7 $50.58
9/15/20235,990,000 shares $312.92 million -5.4%N/A8.2 $52.24
8/31/20236,330,000 shares $314.16 million +8.0%N/A9.3 $49.63
8/15/20235,860,000 shares $278.17 million +1.7%N/A8.9 $47.47
7/31/20235,760,000 shares $249.98 million +5.1%N/A8.6 $43.40
7/15/20235,480,000 shares $249.72 million +14.4%N/A8 $45.57
6/30/20234,790,000 shares $223.65 million +6.2%N/A6.7 $46.69
6/15/20234,510,000 shares $249.00 million -3.8%N/A6.2 $55.21
5/31/20234,690,000 shares $209.08 million +0.9%N/A6.8 $44.58
5/15/20234,650,000 shares $221.85 million No ChangeN/A7 $47.71
4/30/20234,650,000 shares $208.04 million -2.7%N/A7.5 $44.74
4/15/20234,780,000 shares $181.59 million +8.1%N/A7.8 $37.99
3/31/20234,420,000 shares $169.11 million +30.8%N/A7.4 $38.26
3/15/20233,380,000 shares $136.92 million -0.9%N/A5.2 $40.51
2/28/20233,410,000 shares $155.19 million -5.0%N/A4.7 $45.51
2/15/20233,590,000 shares $161.55 million -5.8%N/A4.9 $45.00
1/31/20233,810,000 shares $188.60 million -8.9%N/A5 $49.50
1/15/20234,180,000 shares $210.00 million -20.5%N/A5.5 $50.24
12/30/20225,260,000 shares $288.25 million +27.7%N/A6.9 $54.80
12/15/20224,120,000 shares $181.57 million -16.8%N/A5.2 $44.07
11/30/20224,950,000 shares $230.18 million +21.6%N/A3.2 $46.50
11/15/20224,070,000 shares $182.25 million -12.5%N/A2.7 $44.78
10/31/20224,650,000 shares $196.51 million +17.1%13.5%3.2 $42.26
10/15/20223,970,000 shares $152.85 million -24.7%11.8%2.8 $38.50
9/30/20225,270,000 shares $179.44 million -3.7%17.1%3.8 $34.05
9/15/20225,470,000 shares $145.12 million -11.5%17.8%4.3 $26.53
8/31/20226,180,000 shares $72.62 million +6.6%26.5%15.6 $11.75
8/15/20225,800,000 shares $75.23 million +4.9%24.8%15.9 $12.97
7/31/20225,530,000 shares $56.63 million +6.6%27.4%14.3 $10.24
7/15/20225,190,000 shares $57.30 million +8.6%27.8%13.8 $11.04
6/30/20224,780,000 shares $45.17 million -1.2%25.6%13.1 $9.45
6/15/20224,840,000 shares $41.14 million +3.4%22.8%13.8 $8.50













AKRO Short Interest - Frequently Asked Questions

What is Akero Therapeutics' current short interest?

Short interest is the volume of Akero Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 7,760,000 shares of AKRO short. Learn More on Akero Therapeutics' current short interest.

What is a good short interest ratio for Akero Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKRO shares currently have a short interest ratio of 7.0. Learn More on Akero Therapeutics's short interest ratio.

Which institutional investors are shorting Akero Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Akero Therapeutics: HAP Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, Cutler Group LLC CA, and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Akero Therapeutics' short interest increasing or decreasing?

Akero Therapeutics saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 7,760,000 shares, an increase of 2.1% from the previous total of 7,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Akero Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Akero Therapeutics: Tango Therapeutics, Inc. (20.63%), ANI Pharmaceuticals, Inc. (1.18%), Avadel Pharmaceuticals plc (9.44%), Ligand Pharmaceuticals Incorporated (5.67%), Deciphera Pharmaceuticals, Inc. (10.89%), Edgewise Therapeutics, Inc. (11.47%), Day One Biopharmaceuticals, Inc. (15.49%), Belite Bio, Inc (0.19%), Sage Therapeutics, Inc. (15.28%), MacroGenics, Inc. (14.23%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Akero Therapeutics stock?

Short selling AKRO is an investing strategy that aims to generate trading profit from Akero Therapeutics as its price is falling. AKRO shares are trading up $1.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Akero Therapeutics?

A short squeeze for Akero Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AKRO, which in turn drives the price of the stock up even further.

How often is Akero Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKRO, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:AKRO) was last updated on 2/23/2024 by MarketBeat.com Staff